Citigroup Adjusts Price Target on Henry Schein to $112 From $100
Citigroup raised its price target on Henry Schein to $112 from $100, according to the report. UBS also adjusted its target to $94 from $89 and kept a neutral rating. The changes reflect updated analyst views on the stock’s outlook.
How this was made
The 30-second read
Why it matters
For traders, the actionable element is the direction of the valuation signal (higher target) and the presence of cross-firm disagreement (UBS lower target, Neutral).
Market read
This is a single-company analyst price-target update for HSIC, likely to influence short-term sentiment more than fundamentals.
What to watch
The body also mentions UBS maintaining Neutral with a lower target, implying disagreement that can cap upside follow-through.
Background
The text is a scraped summary of sell-side actions, specifically Citigroup adjusting its Henry Schein price target; it also references UBS’s separate target change.
Ticker impact
Citigroup raised its Henry Schein price target to $112 from $100, signaling a fresh analyst valuation view for HSIC.
Likely modest positive bias for HSIC around the note, with follow-through depending on whether other firms’ targets and estimates align.
The only disclosed new fact is the Citigroup target adjustment; no earnings, guidance, or operational update is provided in the text.
Market effects
Adds incremental read-through to healthcare distribution sentiment, but without new industry data or company-specific fundamentals.
No clear regional spillover beyond US sell-side coverage.
Limited global relevance; this is a US analyst target update for a single company.
Counterpoint
A price-target raise can reflect model/valuation tweaks rather than improved fundamentals, so price reaction may fade if estimates do not move.
Key entities
- companyHenry Schein
Subject of the article, with Citigroup raising its price target to $112 from $100.
- analyst_firmCitigroup
Raised the Henry Schein price target in the note summarized by the article.
- analyst_firmUBS
Maintained a Neutral rating on Henry Schein and set a lower target ($94 from $89) per the article text.
